Wed, Apr 16, 2014, 2:17 PM EDT - U.S. Markets close in 1 hr 43 mins

Recent

% | $
Quotes you view appear here for quick access.

Exelixis, Inc. Message Board

  • residentalert residentalert Dec 6, 2012 1:34 PM Flag

    EntreMed has a drug in PII trials that is similar to cabozantinib

    "ENMD-2076, an Oral Inhibitor of Angiogenic and Proliferation Kinases"
    They also seem to target the same types of cancer. Assuming that the two drugs do not have identical targets, I wonder how they might work in combo?

    Sentiment: Strong Buy

 
EXEL
3.28+0.06(+1.86%)2:16 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.